Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use

Patent metadata

Field	Value
Publication number	US-9427002-B2
Application number	US-201213365868-A
Country	US
Kind code	B2
Filing date	Feb 3, 2012
Priority date	Nov 2, 2005
Publication date	Aug 30, 2016
Grant date	Aug 30, 2016

Abstract

Edible compositions useful for weight management in male animals are disclosed. The compositions comprise one or more isoflavones or isoflavone metabolites and are particularly useful for reducing or preventing the accumulation of body fat. Also disclosed are methods useful for weight management in an animal utilizing compositions comprising one or more isoflavones. The compositions and methods are particularly useful for the reduction or prevention of body fat accumulation during periods of excess caloric intake, and preferably have a sparing effect on lean body mass.

First claim

What is claimed:

1. A method for reducing fat accumulation in a canine consuming calories in excess of its minimum daily requirement, the method comprising identifying a canine, determining that the canine is consuming calories in excess of its minimum daily requirement, and providing to the canine on a regular basis a comestible composition comprising one or more isoflavones that metabolize to equol in an amount effective for reducing deposition of subcutaneous or intramuscular fat in the body of the canine.

2. The method of claim 1 , wherein the one or more isoflavones are from soy bean.

3. The method of claim 1 , wherein the comestible composition is a pet food, or a food supplement to be taken directly or added to a pet food, or to animal feed.

4. The method of claim 1 , wherein the canine is a male canine.

5. The method of claim 1 , wherein the canine is a puppy.

6. The method of claim 1 , wherein the composition is provided by administering to the canine on a daily basis.

7. The method of claim 1 , wherein the canine has not been neutered and is not post-andropausal.

8. The method of claim 7 , further comprising the step of determining that the canine is beyond the mid-point of the life expectancy for its species or breed.

9. The method of claim 1 , further comprising determining that the canine has been neutered; or is post-andropausal; or has reduced circulating estradiol concentrations relative to a healthy, nonobese male animal of the same species or breed; or has reduced ability to convert testosterone into estradiol relative to a healthy, nonobese male animal of the same species or breed; or has reduced aromatase activity relative to a healthy, nonobese male animal of the same species or breed.

10. The method of claim 9 , further comprising the step of determining that the circulating estradiol of the canine is less than about 80% of a healthy, nonobese male animal of the same species or breed.

11. The method of claim 9 , further comprising the step of determining that the circulating estradiol of the canine is less than about 50% of a healthy, nonobese male animal of the same species or breed.

12. The method of claim 9 , further comprising the step of determining that the circulating estradiol of the canine is less than about 20% of a healthy, nonobese male animal of the same species or breed.

13. The method of claim 9 , further comprising the step of determining that the circulating estradiol of the canine is less than about 10% of a healthy, nonobese animal of the same species or breed.

14. The method of claim 1 , wherein the comestible composition is provided to the canine before it reaches a normal adult body weight.

Assignees

• Pan Yuanlong
• Nestec Sa

Inventors

• Pan Yuanlong

Classifications

• A61P3/06

  Antihyperlipidemics · CPC title

• A61P3/04

  Anorexiants; Antiobesity agents · CPC title

• A61P3/00

  Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

• A23L33/10

  using additives (addition of substantially indigestible substances A23L33/21) · CPC title

• A23K20/10 Primary

  Organic substances · CPC title